4.7 Review

Pathological Roles of Pulmonary Cells in Acute Lung Injury: Lessons from Clinical Practice

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Biochemistry & Molecular Biology

Molecular basis of the potential interaction of SARS-CoV-2 spike protein to CD147 in COVID-19 associated-lymphopenia

Mohamed A. Helal et al.

Summary: Lymphopenia is a characteristic feature of COVID-19, possibly due to the entry of SARS-CoV-2 into T cells through the CD147 receptor. Research shows that the viral spike protein binds to CD147 via electrostatic interactions, providing insights for potential treatment strategies against the virus.

JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2022)

Article Medicine, General & Internal

Molnupiravir for Oral Treatment of Covid-19 in Nonhospitalized Patients

A. Jayk Bernal et al.

Summary: This study found that early treatment with molnupiravir reduced the risk of hospitalization or death in at-risk, unvaccinated adults with Covid-19.

NEW ENGLAND JOURNAL OF MEDICINE (2022)

Article Medicine, General & Internal

Oral Nirmatrelvir for High-Risk, Nonhospitalized Adults with Covid-19

Jennifer Hammond et al.

Summary: In high-risk, unvaccinated adults, treatment of Covid-19 with nirmatrelvir plus ritonavir can significantly reduce the risk of hospitalization and death, with good safety profile.

NEW ENGLAND JOURNAL OF MEDICINE (2022)

Article Rheumatology

Intravenous immunoglobulin for interstitial lung diseases of anti-melanoma differentiation-associated gene 5-positive dermatomyositis

Li-Mei Wang et al.

Summary: This study found that IVIG is a highly effective initial treatment for patients with MDA5-RPILD. By reducing ferritin concentration, anti-MDA5 titre, and GGO score, IVIG may increase survival and remission rate in patients.

RHEUMATOLOGY (2022)

Article Multidisciplinary Sciences

New risk scoring system for predicting 3-month mortality after acute exacerbation of idiopathic pulmonary fibrosis

Susumu Sakamoto et al.

Summary: The study aimed to develop a multidimensional prognostic staging system for AE-IPF using commonly measured clinical variables. Data from IPF patients were analyzed and a clinical prediction model was developed. The model accurately predicted 3-month mortality in AE-IPF patients.

SCIENTIFIC REPORTS (2022)

Article Medicine, General & Internal

Low Circulating Monocytes Is in Parallel With Lymphopenia Which Predicts Poor Outcome in Anti-melanoma Differentiation-Associated Gene 5 Antibody-Positive Dermatomyositis-Associated Interstitial Lung Disease

Xia Lv et al.

Summary: This study revealed that in patients with anti-MDA5 antibody-positive dermatomyositis, lymphocyte and monocyte counts early in the disease course may serve as predictive biomarkers for 6-month all-cause mortality, with lower counts indicating higher risk of death.

FRONTIERS IN MEDICINE (2022)

Article Critical Care Medicine

Idiopathic Pulmonary Fibrosis (an Update) and Progressive Pulmonary Fibrosis in Adults An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline

Ganesh Raghu et al.

Summary: This article provides updates on the guidelines for idiopathic pulmonary fibrosis (IPF) and addresses the progression of pulmonary fibrosis in patients with interstitial lung diseases (ILDs) other than IPF. The recommendations are based on consensus and systematic reviews, aiming to provide evidence-based guidance for clinicians.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2022)

Letter Critical Care Medicine

COVID-19 Vaccine in Patients with Exacerbation of Idiopathic Pulmonary Fibrosis

Giacomo Sgalla et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2022)

Article Biochemistry & Molecular Biology

Multiplatform Single-Cell Analysis Identifies Immune Cell Types Enhanced in Pulmonary Fibrosis

Ana P. M. Serezani et al.

Summary: By studying immune cell subsets and transcriptional profiles, this research reveals increased and activated immune cells in the lungs of IPF patients, indicating the importance of IFN-γ signaling and adaptive immunity in the pathogenesis of IPF.

AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2022)

Article Cardiac & Cardiovascular Systems

The current status of thrombosis and anticoagulation therapy in patients with COVID-19 in Japan: From the CLOT-COVID study

Yuji Nishimoto et al.

Summary: This study provides important insights into the real-world management strategies for anticoagulation therapy in patients with COVID-19. The results show that pharmacological thromboprophylaxis is common, especially in severe COVID-19 patients, but there is wide variation in management strategies across different centers. The incidence of thrombosis increases with the severity of the disease.

JOURNAL OF CARDIOLOGY (2022)

Article Multidisciplinary Sciences

Inhibition of lung microbiota-derived proapoptotic peptides ameliorates acute exacerbation of pulmonary fibrosis

Corina N. D'Alessandro-Gabazza et al.

Summary: The authors demonstrate that a monoclonal neutralizing antibody against the proapoptotic peptide corisin, derived from the lung microbiota, can improve acute exacerbation of pulmonary fibrosis and the severity of endotoxin-induced acute lung injury in mice. The study provides insights into the processing and release of corisin and shows that an anticorisin monoclonal antibody can ameliorate lung fibrosis and acute lung injury. These findings highlight the role of corisin in the pathogenesis of the diseases and offer a novel approach to treating the incurable disease.

NATURE COMMUNICATIONS (2022)

Article Multidisciplinary Sciences

Changes in blood Krebs von den Lungen-6 predict the mortality of patients with acute exacerbation of interstitial lung disease

Myeong Geun Choi et al.

Summary: This study investigated the best prognostic biomarker for patients with AE-ILD and found that the relative changes in KL-6 may be helpful in predicting in-hospital mortality.

SCIENTIFIC REPORTS (2022)

Article Critical Care Medicine

Cyclophosphamide added to glucocorticoids in acute exacerbation of idiopathic pulmonary fibrosis (EXAFIP): a randomised, double-blind, placebo-controlled, phase 3 trial

Jean-Marc Naccache et al.

Summary: The efficacy of cyclophosphamide in patients with acute exacerbation of idiopathic pulmonary fibrosis (IPF) is uncertain. The study suggests that adding cyclophosphamide to glucocorticoids increases the 3-month mortality rate in these patients.

LANCET RESPIRATORY MEDICINE (2022)

Article Medicine, General & Internal

Association of Receiving a Fourth Dose of the BNT162b Vaccine With SARS-CoV-2 Infection Among Health Care Workers in Israel

Matan J. Cohen et al.

Summary: Despite high vaccination rates among health care workers in Israel, a significant number of breakthrough infections were observed during the Omicron wave. A fourth vaccine dose was recommended to mitigate the infection rate. This study found that the fourth dose of the vaccine reduced breakthrough infection rates among hospital staff, although not as much as the third dose.

JAMA NETWORK OPEN (2022)

Article Respiratory System

Frequency, proportion of PF-ILD, and prognostic factors in patients with acute exacerbation of ILD related to systemic autoimmune diseases

Noriyuki Enomoto et al.

Summary: This retrospective study analyzed data of patients with SAID-ILD between 1999 and 2020 to determine the incidences of AE-ILD in each SAID and the proportion of PF-ILD in AE-SAID-ILD. The study found that the incidence of AE-SAID-ILD was significantly higher in patients with RA, MPA, or SSc than in patients with other SAID. Additionally, the proportion of PF-ILD just before AE in AE-SAID-ILD was not high (20%).

BMC PULMONARY MEDICINE (2022)

Article Public, Environmental & Occupational Health

Mortality Risk Among Patients Hospitalized Primarily for COVID-19 During the Omicron and Delta Variant Pandemic Periods — United States, April 2020–June 2022

Stacey Adjei et al.

MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2022)

Article

Management of COVID-19: A comprehensive and practical approach

M.S. Barthwal et al.

Medical Journal Armed Forces India (2022)

Article Rheumatology

Clinical significance of HScore and MS score comparison in the prognostic evaluation of anti-MDA5-positive patients with dermatomyositis and interstitial lung disease

Shengnan Zhao et al.

Summary: This study evaluates the clinical significance of HScore and MS score in predicting the prognosis of anti-MDA5-positive DM-ILD patients. It found that older age, male gender, and high HScore were independent risk factors for mortality among these patients.

MODERN RHEUMATOLOGY (2022)

Article Respiratory System

Acute exacerbation of rheumatoid arthritis-associated interstitial lung disease: mortality and its prediction model

Hironao Hozumi et al.

Summary: This study found that post-AE mortality was high in patients with AE-RA-ILD, similar to AE-IPF patients. The study also created a predictive model for AE-RA-ILD mortality, which can aid in the management of these patients.

RESPIRATORY RESEARCH (2022)

Article Rheumatology

Antiviral proinflammatory phenotype of monocytes in anti-MDA5 antibody-associated interstitial lung disease

Takahisa Gono et al.

Summary: An antiviral proinflammatory network orchestrated primarily by activated monocytes/macrophages might be responsible for cytokine storm in patients with anti-MDA5-associated interstitial lung disease.

RHEUMATOLOGY (2022)

Article Respiratory System

COVID-19 and acute exacerbation of interstitial lung disease

Yasuhiro Kondoh et al.

Summary: The study examined the impact of COVID-19 on acute exacerbation of interstitial lung disease (AE-ILD) early in the pandemic, showing that COVID-19-related AE-ILD had a worse prognosis compared to non-COVID-19-related exacerbations. Preventing COVID-19 is crucial for patients with ILD due to the extremely poor prognosis associated with COVID-19.

RESPIRATORY INVESTIGATION (2021)

Article Respiratory System

Serum S100A8 and S100A9 as prognostic biomarkers in acute exacerbation of idiopathic pulmonary fibrosis

Kazuki Tanaka et al.

Summary: The study demonstrated that serum levels of S100A8 and S100A9 were significantly higher in patients with AE-IPF compared to healthy controls and patients at IPF diagnosis. Elevated levels of S100A8 and S100A9 during hospitalization were associated with worse prognosis in patients with AE-IPF.

RESPIRATORY INVESTIGATION (2021)

Article Biochemistry & Molecular Biology

Synergism of TNF-α and IFN-γ Triggers Inflammatory Cell Death, Tissue Damage, and Mortality in SARS-CoV-2 Infection and Cytokine Shock Syndromes

Rajendra Karki et al.

Summary: The combination of TNF-alpha and IFN-gamma induces inflammatory cell death characterized by PANoptosis, which can be inhibited to protect mice from the pathological effects and death caused by COVID-19. Blocking the cytokine-mediated inflammatory cell death signaling pathway may benefit patients with COVID-19 or other infectious and autoinflammatory diseases by limiting tissue damage/inflammation.
Article Respiratory System

Hemosiderin-Laden Macrophages in Bronchoalveolar Lavage: Predictive Role for Acute Exacerbation of Idiopathic Interstitial Pneumonias

Toru Arai et al.

Summary: This retrospective study found that hemosiderin-laden macrophages (HLMs) in bronchoalveolar lavage fluid (BALF) could predict the acute exacerbation (AE) of chronic idiopathic interstitial pneumonias (IIPs), with higher HS values leading to earlier AE occurrences. A higher HS value was a significant predictor of AE in IIPs, but did not significantly enhance the predictive ability of other parameters such as IPF, forced vital capacity, and modified Medical Research Council score.

CANADIAN RESPIRATORY JOURNAL (2021)

Article Critical Care Medicine

Pathophysiology of Acute Respiratory Distress Syndrome and COVID-19 Lung Injury

Kai Erik Swenson et al.

CRITICAL CARE CLINICS (2021)

Review Medicine, Research & Experimental

Immune dysregulation as a driver of idiopathic pulmonary fibrosis

Kevin Shenderov et al.

Summary: IPF is a debilitating disease with limited treatment options, with lung transplantation being the only cure. Recent research has highlighted immune dysregulation as a key factor in the pathophysiology of the disease, suggesting that a better understanding of the immune system's role in IPF may lead to the development of targeted therapies.

JOURNAL OF CLINICAL INVESTIGATION (2021)

Review Neurosciences

Silent hypoxaemia in COVID-19 patients

Tatum S. Simonson et al.

Summary: The clinical presentation of COVID-19 can vary greatly, with some patients having mild symptoms while others develop respiratory failure. Some patients with COVID-19 are identified as having 'happy hypoxia', exhibiting no observable signs of respiratory distress despite feeling breathless. Further investigation is needed to understand the underlying respiratory and neurological components contributing to this variation.

JOURNAL OF PHYSIOLOGY-LONDON (2021)

Article Medicine, General & Internal

Repurposed Antiviral Drugs for Covid-19-Interim WHO Solidarity Trial Results

Summary: The authors of the study reported the interim results of using four repurposed antiviral drugs (remdesivir, hydroxychloroquine, lopinavir, and interferon beta-1a) in hospitalized COVID-19 patients. The study showed that these drug regimens had little or no effect on overall mortality, initiation of ventilation, and duration of hospital stay.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Article Medicine, General & Internal

Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19

A. C. Kalil et al.

Summary: Combination treatment with baricitinib plus remdesivir was superior to remdesivir alone in reducing recovery time and accelerating improvement in clinical status among patients with Covid-19, notably among those receiving high-flow oxygen or noninvasive ventilation. The combination was associated with fewer serious adverse events.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Review Cardiac & Cardiovascular Systems

Pulmonary pathology of ARDS in COVID-19: A pathological review for clinicians

Sabrina Setembre Batah et al.

Summary: COVID-19 caused by SARS-CoV-2 is a global pandemic, with patients progressing from flu-like symptoms to severe acute lung injury characterized by acute and diffuse inflammatory damage to the alveolar-capillary barrier.

RESPIRATORY MEDICINE (2021)

Article Cell Biology

Gefitinib initiates sterile inflammation by promoting IL-1β and HMGB1 release via two distinct mechanisms

Takuya Noguchi et al.

Summary: The anticancer drug gefitinib triggers pro-inflammatory responses by promoting the release of IL-1 beta and HMGB1. While IL-1 beta release is regulated by the NLRP3 inflammasome, HMGB1 release is mediated through a different mechanism involving mtROS-induced DNA damage. This study sheds light on the mechanisms underlying gefitinib-induced inflammation and its potential implications for interstitial pneumonitis.

CELL DEATH & DISEASE (2021)

Article Biochemistry & Molecular Biology

Time-resolved systems immunology reveals a late juncture linked to fatal COVID-19

Can Liu et al.

Summary: This study longitudinally assessed various factors in single peripheral immune cells of COVID-19 patients and identified primary correlates of disease severity and outcome. Timing was emphasized as crucial in the analysis, clinical monitoring, and therapeutic intervention of COVID-19.
Article Medicine, General & Internal

Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19

Anthony C. Gordon et al.

Summary: Interleukin-6 receptor antagonists tocilizumab and sarilumab were found to improve outcomes, including survival, in critically ill patients with Covid-19 receiving organ support in ICUs according to an ongoing international trial. The efficacy of these treatments has been confirmed, with patients benefiting from the therapy.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Article Cell Biology

Lung epithelial and endothelial damage, loss of tissue repair, inhibition of fibrinolysis, and cellular senescence in fatal COVID-19

Felice D'Agnillo et al.

Summary: This study identified significant pulmonary pathological features in fatal COVID-19 cases, including progressive diffuse alveolar damage, excessive thrombosis, and delayed pulmonary tissue and vascular remodeling. Acute damage at the alveolar-capillary barrier was characterized by loss of surfactant protein expression and injury to various types of cells, such as alveolar epithelial cells and endothelial cells. These findings provide insights into potential therapeutic targets for treating SARS-CoV-2 infection-induced respiratory distress.

SCIENCE TRANSLATIONAL MEDICINE (2021)

Article Cell Biology

Metabolic programs define dysfunctional immune responses in severe COVID-19 patients

Elizabeth A. Thompson et al.

Summary: The study identifies a unique population of T cells expressing increased VDAC1 in severe and recovered COVID-19 patients, associated with mitochondrial dysfunction and apoptosis. Additionally, specific metabolic phenotypes of myeloid-derived suppressor cells in COVID-19 patients can distinguish between severe and mild disease. These findings offer insight into dysfunctional immune response in COVID-19 patients and potential for developing personalized therapeutic approaches.

CELL REPORTS (2021)

Article Multidisciplinary Sciences

Identification and characterization of a SARS-CoV-2 specific CD8+ T cell response with immunodominant features

Anastasia Gangaev et al.

Summary: This study identified a range of SARS-CoV-2 CD8(+) T cell responses across COVID-19 patients, including an epitope from ORF1ab with immunodominant features. The specific CD8(+) T cell responses can still be detectable up to 5 months after recovery from critical and severe disease, converting from dysfunctional effector cells to functional memory cells during convalescence.

NATURE COMMUNICATIONS (2021)

Article Respiratory System

2020 guide for the diagnosis and treatment of interstitial lung disease associated with connective tissue disease

Yasuhiro Kondoh et al.

Summary: The prognosis of patients with connective tissue disease (CTD) has improved, but interstitial lung disease (ILD) associated with CTD remains a refractory condition and a leading cause of mortality. The guide focusing on CTD-ILD, published through collaboration between Japanese Respiratory Society and Japan College of Rheumatology, aims to help standardize medical care for CTD-ILD and promote future research by addressing unresolved issues.

RESPIRATORY INVESTIGATION (2021)

Article Oncology

Association of serum monomeric periostin level with outcomes of acute exacerbation of idiopathic pulmonary fibrosis and fibrosing nonspecific interstitial pneumonia

Hiroshige Shimizu et al.

Summary: The study of 37 AE-FIP patients found that serial change in serum M-PN level may serve as a prognostic indicator for AE-FIP, with higher Delta M-PN associated with 3-month survival rate.

ANNALS OF TRANSLATIONAL MEDICINE (2021)

Article Biotechnology & Applied Microbiology

Neutrophil Extracellular Traps in Fatal COVID-19-Associated Lung Injury

Astrid Obermayer et al.

Summary: The study found that NETs are abundantly present in seriously damaged COVID-19 lung tissue, especially in association with microthrombi of the alveolar capillaries. Low-density neutrophils (LDNs) significantly contribute to COVID-19-associated lung damage and vascular blockages.

DISEASE MARKERS (2021)

Article Cardiac & Cardiovascular Systems

Prognostic significance of bronchoalveolar lavage cellular analysis in patients with acute exacerbation of interstitial lung disease

Masato Kono et al.

Summary: This study retrospectively reviewed 71 patients with acute exacerbation of interstitial lung disease who underwent bronchoalveolar lavage and found that cellular analysis of bronchoalveolar lavage fluid may serve as a potential biomarker for predicting prognosis after acute exacerbation.

RESPIRATORY MEDICINE (2021)

Article Medicine, General & Internal

Risk factors for severity on admission and the disease progression during hospitalisation in a large cohort of patients with COVID-19 in Japan

Mari Terada et al.

Summary: This study aimed to investigate the risk factors contributing to severity on admission, worst severity, and fatality in COVID-19 patients. Results showed that older age, male gender, cardiovascular disease, chronic respiratory disease, diabetes, obesity, and hypertension were risk factors for severity on admission. Additionally, risk factors varied when considering worst severity and fatality.

BMJ OPEN (2021)

Article Critical Care Medicine

Efficacy and safety of baricitinib for the treatment of hospitalised adults with COVID-19 (COV-BARRIER) : a randomised, double-blind, parallel-group, placebo- controlled phase 3 trial

Vincent C. Marconi et al.

Summary: Although there was no significant reduction in the frequency of disease progression overall, treatment with baricitinib in addition to standard of care (including dexamethasone) had a similar safety profile to that of standard care alone, and was associated with reduced mortality in hospitalised adults with COVID-19.

LANCET RESPIRATORY MEDICINE (2021)

Review Cell Biology

Cell Death in Coronavirus Infections: Uncovering Its Role during COVID-19

Annamaria Paolini et al.

Summary: Cell death mechanisms play a crucial role in maintaining a healthy cellular environment, but dysregulation of these processes during viral infections can contribute to disease pathology. In COVID-19 patients, lymphopenia and monocytopenia are important factors in immunopathogenesis, and the underlying mechanisms are still not fully understood. Further research is needed to develop new therapeutic strategies for COVID-19.
Review Radiology, Nuclear Medicine & Medical Imaging

COVID-19 pneumonia: current evidence of chest imaging features, evolution and prognosis

Anna Rita Larici et al.

Summary: Chest imaging, including X-ray and HRCT, plays a crucial role in the initial evaluation and follow-up of COVID-19 pneumonia patients, aiding in assessing disease severity and predicting patient outcomes.

CHINESE JOURNAL OF ACADEMIC RADIOLOGY (2021)

Article Respiratory System

COVID-19 versus Non-COVID-19 Acute Respiratory Distress Syndrome Comparison of Demographics, Physiologic Parameters, Inflammatory Biomarkers, and Clinical Outcomes

William Bain et al.

Summary: COVID-19 ARDS and ARDS from other etiologies have differences in demographic, physiologic parameters, and clinical outcomes, such as IL-6 levels and minute ventilation. Despite some similarities, COVID-19 ARDS shows longer duration of mechanical ventilation compared to other ARDS patients.

ANNALS OF THE AMERICAN THORACIC SOCIETY (2021)

Review Medicine, General & Internal

Management of Myositis-Associated Interstitial Lung Disease

Tomoyuki Fujisawa

Summary: Idiopathic inflammatory myopathies, such as polymyositis (PM), dermatomyositis (DM), and clinically amyopathic DM (CADM), are autoimmune diseases characterized by muscular and extramuscular manifestations. Interstitial lung disease (ILD) is a major pulmonary complication associated with increased mortality in these conditions. Treatment of ILD associated with PM/DM/CADM requires careful evaluation of disease severity, clinical subtype, and specific autoantibody status to determine optimal therapy.

MEDICINA-LITHUANIA (2021)

Article Respiratory System

Prednisolone and tacrolimus versus prednisolone and cyclosporin A to treat polymyositis/dermatomyositis-associated ILD: A randomized, open-label trial

Tomoyuki Fujisawa et al.

Summary: This study aimed to compare the efficacy of TAC and CsA regimens as initial treatments for patients with PM/DM-ILD. Results showed that PSL plus TAC treatment may achieve a better short-term PFS rate, while PSL plus CsA treatment had a slight advantage in the OS rate at 52 weeks. Additionally, both groups showed significant improvements in pulmonary function tests, with no treatment discontinuations due to adverse events.

RESPIROLOGY (2021)

Article Critical Care Medicine

Thrombomodulin Alfa for Acute Exacerbation of Idiopathic Pulmonary Fibrosis A Randomized, Double-Blind Placebo-controlled Trial

Yasuhiro Kondoh et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2020)

Article Radiology, Nuclear Medicine & Medical Imaging

Ultra-high-resolution computed tomography can demonstrate alveolar collapse in novel coronavirus (COVID-19) pneumonia

Tae Iwasawa et al.

JAPANESE JOURNAL OF RADIOLOGY (2020)

Article Multidisciplinary Sciences

A Staphylococcus pro-apoptotic peptide induces acute exacerbation of pulmonary fibrosis

Corina N. D'Alessandro-Gabazza et al.

NATURE COMMUNICATIONS (2020)

Article Respiratory System

Pathogenesis of COVID-19-induced ARDS: implications for an ageing population

Manuel A. Torres Acosta et al.

EUROPEAN RESPIRATORY JOURNAL (2020)

Article Biochemistry & Molecular Biology

Elevated Calprotectin and Abnormal Myeloid Cell Subsets Discriminate Severe from Mild COVID-19

Aymeric Silvin et al.

Editorial Material Immunology

The ORF3a protein of SARS-CoV-2 induces apoptosis in cells

Yujie Ren et al.

CELLULAR & MOLECULAR IMMUNOLOGY (2020)

Article Medicine, General & Internal

Genomewide Association Study of Severe Covid-19 with Respiratory Failure

David Ellinghaus et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Article Medicine, Research & Experimental

Altered bioenergetics and mitochondrial dysfunction of monocytes in patients with COVID-19 pneumonia

Lara Gibellini et al.

EMBO MOLECULAR MEDICINE (2020)

Article Biochemistry & Molecular Biology

A dynamic COVID-19 immune signature includes associations with poor prognosis

Adam G. Laing et al.

NATURE MEDICINE (2020)

Article Biochemistry & Molecular Biology

SARS-CoV-2 triggers inflammatory responses and cell death through caspase-8 activation

Shufen Li et al.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)

Article Radiology, Nuclear Medicine & Medical Imaging

Pulmonary Vascular Manifestations of COVID-19 Pneumonia

Min Lang et al.

RADIOLOGY-CARDIOTHORACIC IMAGING (2020)

Letter Critical Care Medicine

Serum levels of receptor-interacting protein kinase-3 in patients with COVID-19

Hideta Nakamura et al.

CRITICAL CARE (2020)

Article Respiratory System

Acute exacerbation of unclassifiable idiopathic interstitial pneumonia: comparison with idiopathic pulmonary fibrosis

Noriyuki Enomoto et al.

THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE (2020)

Article Medicine, General & Internal

Nintedanib for Systemic Sclerosis-Associated Interstitial Lung Disease

Oliver Distler et al.

NEW ENGLAND JOURNAL OF MEDICINE (2019)

Article Critical Care Medicine

Tracking Impact of Interstitial Lung Disease in Systemic Sclerosis in a Complete Nationwide Cohort

Anna-Maria Hoffmann-Vold et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2019)

Article Multidisciplinary Sciences

Analysis of serum adiponectin and leptin in patients with acute exacerbation of idiopathic pulmonary fibrosis

Noriyuki Enomoto et al.

SCIENTIFIC REPORTS (2019)

Article Medicine, General & Internal

Nintedanib in Progressive Fibrosing Interstitial Lung Diseases

K. R. Flaherty et al.

NEW ENGLAND JOURNAL OF MEDICINE (2019)

Article Respiratory System

Prognostic evaluation of serum ferritin in acute exacerbation of idiopathic pulmonary fibrosis

Noriyuki Enomoto et al.

CLINICAL RESPIRATORY JOURNAL (2018)

Article Respiratory System

Acute exacerbations in the INPULSIS trials of nintedanib in idiopathic pulmonary fibrosis

Harold R. Collard et al.

EUROPEAN RESPIRATORY JOURNAL (2017)

Review Physiology

The endothelium in hypoxic pulmonary vasoconstriction

Benjamin Grimmer et al.

JOURNAL OF APPLIED PHYSIOLOGY (2017)

Article Multidisciplinary Sciences

Chemokine profiles of interstitial pneumonia in patients with dermatomyositis: a case control study

Katsuhiro Oda et al.

SCIENTIFIC REPORTS (2017)

Article Critical Care Medicine

Roles of Periostin in Respiratory Disorders

Kenji Izuhara et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2016)

Review Critical Care Medicine

Acute Exacerbation of Idiopathic Pulmonary Fibrosis An International Working Group Report

Harold R. Collard et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2016)

Article Cardiac & Cardiovascular Systems

Nintedanib in patients with idiopathic pulmonary fibrosis: Combined evidence from the TOMORROW and INPULSIS® trials

Luca Richeldi et al.

RESPIRATORY MEDICINE (2016)

Article Respiratory System

Risk factors for an acute exacerbation of idiopathic pulmonary fibrosis

Tomoyuki Kakugawa et al.

RESPIRATORY RESEARCH (2016)

Article Multidisciplinary Sciences

Macrophage Activation in Acute Exacerbation of Idiopathic Pulmonary Fibrosis

Jonas Christian Schupp et al.

PLOS ONE (2015)

Review Physiology

Diverse macrophage populations mediate acute lung inflammation and resolution

Neil R. Aggarwal et al.

AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2014)

Article Critical Care Medicine

Epidemiologic Survey of Japanese Patients with Idiopathic Pulmonary Fibrosis and Investigation of Ethnic Differences

Motoki Natsuizaka et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2014)

Article Cardiac & Cardiovascular Systems

Impact and predictors of acute exacerbation of interstitial lung diseases after pulmonary resection for lung cancer

Toshihiko Sato et al.

JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY (2014)

Article Rheumatology

Diffuse alveolar damage in patients with dermatomyositis: a six-case series

Yuko Matsuki et al.

Modern Rheumatology (2014)

Article Multidisciplinary Sciences

Prognostic Factors for Myositis-Associated Interstitial Lung Disease

Tomoyuki Fujisawa et al.

PLOS ONE (2014)

Review Immunology

Myositis autoantibodies and clinical phenotypes

Anna Ghirardello et al.

AUTOIMMUNITY HIGHLIGHTS (2014)

Article Respiratory System

Autopsy analyses in acute exacerbation of idiopathic pulmonary fibrosis

Keishi Oda et al.

RESPIRATORY RESEARCH (2014)

Article Critical Care Medicine

Patients with Idiopathic Pulmonary Fibrosis with Antibodies to Heat Shock Protein 70 Have Poor Prognoses

Rehan A. Kahloon et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2013)

Article Immunology

A Protective Hsp70-TLR4 Pathway in Lethal Oxidant Lung Injury

Yi Zhang et al.

JOURNAL OF IMMUNOLOGY (2013)

Article Cardiac & Cardiovascular Systems

The prognostic value of HRCT in myositis-associated interstitial lung disease

Kiminobu Tanizawa et al.

RESPIRATORY MEDICINE (2013)

Review Respiratory System

Acute exacerbations in patients with idiopathic pulmonary fibrosis

Dong Soon Kim

RESPIRATORY RESEARCH (2013)

Review Respiratory System

Consensus statement for the diagnosis and treatment of drug-induced lung injuries

Keishi Kubo et al.

RESPIRATORY INVESTIGATION (2013)

Article Respiratory System

Bronchoalveolar lavage pepsin in acute exacerbation of idiopathic pulmonary fibrosis

J. S. Lee et al.

EUROPEAN RESPIRATORY JOURNAL (2012)

Article Medicine, General & Internal

Interstitial lung disease in connective tissue disorders

Aryeh Fischer et al.

LANCET (2012)

Article Medicine, General & Internal

Prednisone, Azathioprine, and N-Acetylcysteine for Pulmonary Fibrosis

Ganesh Raghu et al.

NEW ENGLAND JOURNAL OF MEDICINE (2012)

Article Respiratory System

Acute Exacerbation of Idiopathic Pulmonary Fibrosis: Outcome and Prognostic Factors

Virginie Simon-Blancal et al.

RESPIRATION (2012)

Article Cardiac & Cardiovascular Systems

Acute exacerbation of IPF following diagnostic bronchoalveolar lavage procedures

Koji Sakamoto et al.

RESPIRATORY MEDICINE (2012)

Review Critical Care Medicine

Clinical Course and Prediction of Survival in Idiopathic Pulmonary Fibrosis

Brett Ley et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2011)

Article Critical Care Medicine

An Official ATS/ERSARS/ALAT Statement: Idiopathic Pulmonary Fibrosis: Evidence-based Guidelines for Diagnosis and Management

Ganesh Raghu et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2011)

Article Respiratory System

Acute exacerbation of idiopathic pulmonary fibrosis: incidence, risk factors and outcome

J. W. Song et al.

EUROPEAN RESPIRATORY JOURNAL (2011)

Article Cardiac & Cardiovascular Systems

HRCT features of interstitial lung disease in dermatomyositis with anti-CADM-140 antibody

Kiminobu Tanizawa et al.

RESPIRATORY MEDICINE (2011)

Article Physiology

Plasma biomarker profiles in acute exacerbation of idiopathic pulmonary fibrosis

Harold R. Collard et al.

AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2010)

Article Critical Care Medicine

Serum CC-Chemokine Ligand 18 Concentration Predicts Outcome in Idiopathic Pulmonary Fibrosis

Antje Prassel et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2009)

Article Critical Care Medicine

Gene Expression Profiles of Acute Exacerbations of Idiopathic Pulmonary Fibrosis

Kazuhisa Konishi et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2009)

Article Cardiac & Cardiovascular Systems

Acute exacerbation of interstitial pneumonia associated with collagen vascular diseases

Takafumi Suda et al.

RESPIRATORY MEDICINE (2009)

Letter Critical Care Medicine

Basis of acute exacerbation of idiopathic pulmonary fibrosis in Japanese patients

Arata Azuma et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2008)

Article Critical Care Medicine

Computed tomography findings in acute exacerbation of idiopathic pulmonary fibrosis

Masanori Akira et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2008)

Article Critical Care Medicine

Interstitial lung disease in Japanese patients with lung cancer - A cohort and nested case-control study

Shoji Kudoh et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2008)

Article Cardiac & Cardiovascular Systems

High-resolution computed tomography patterns and immunopathogenetic findings in drug-induced pneumonitis

Keiko Takatani et al.

RESPIRATORY MEDICINE (2008)

Article Critical Care Medicine

Acute exacerbations of idiopathic pulmonary fibrosis

Harold R. Collard et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2007)

Article Critical Care Medicine

Prognosis of fibrotic interstitial pneumonia - Idiopathic versus collagen vascular disease-related subtypes

Joo Hun Park et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2007)

Article Respiratory System

Interstitial lung diseases associated with amyopathic dermatomyositis

T. Suda et al.

EUROPEAN RESPIRATORY JOURNAL (2006)

Article Cardiac & Cardiovascular Systems

Acute exacerbation of interstitial pneumonia following surgical lung biopsy

Yasuhiro Kondoh et al.

RESPIRATORY MEDICINE (2006)

Article Respiratory System

Acute exacerbation of idiopathic pulmonary fibrosis: frequency and clinical features

DS Kim et al.

EUROPEAN RESPIRATORY JOURNAL (2006)

Article Respiratory System

Circulating KL-6 levels in patients with drug induced pneumonitis

H Ohnishi et al.

THORAX (2003)

Article Medicine, General & Internal

Severe acute interstitial pneumonia and gefitinib

A Inoue et al.

LANCET (2003)